Extending subcutaneous rituximab maintenance therapy from 2 years until progression versus observation in patients with indolent non-Hodgkin's lymphoma: interim safety data from the MABCUTE study

Affiliation auteurs!!!! Error affiliation !!!!
TitreExtending subcutaneous rituximab maintenance therapy from 2 years until progression versus observation in patients with indolent non-Hodgkin's lymphoma: interim safety data from the MABCUTE study
Type de publicationJournal Article
Year of Publication2014
AuteursRule S., Briones J., Carella A.M, Casasnovas O., Barreto W.G, Pocock C., Osborne S., Smith R., Zaja F.
JournalBRITISH JOURNAL OF HAEMATOLOGY
Volume165
Pagination67–68
Date PublishedMAY
Type of ArticleMeeting Abstract
ISSN0007-1048